Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
NCT ID: NCT05725005
Description: Safety population included all participants who received at least one dose of the study drug.
Frequency Threshold: 5
Time Frame: Baseline up to end of the study (approximately 4.5 months)
Study: NCT05725005
Study Brief: PET Study of Repeated ASN51 in Healthy Volunteers
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Group 1: ASN51 Low Dose Participants received low dose of ASN51, orally, QD for 14 days in fasted or fed state. 0 None 0 6 4 6 View
Group 2: ASN51 High Dose Participants received high dose of ASN51, orally, QD for 14 days in fasted or fed state. 0 None 0 6 3 6 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 26.0 View
Lethargy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 26.0 View
Dermatitis contact SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 26.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 26.0 View
Hordeolum SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 26.0 View
Epistaxis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 26.0 View
Catheter site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 26.0 View
Catheter site related reaction SYSTEMATIC_ASSESSMENT General disorders MedDRA 26.0 View